Skip to main navigation Skip to search Skip to main content

A Phase 2, Randomised, Double-blind, Placebo-controlled, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous BRB-002 in Patients with Established Atherosclerosis

  • Better, Nathan (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date1/07/25 → 30/06/27

Keywords

  • Clinical Trial
  • BRB-002-201

Clinical Trial Phase

  • Phase II
  • External Sponsor